VANCOUVER, British Columbia, June 30, 2021 (GLOBE NEWSWIRE) — EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), announced today that Mr. Morten Borch and Mr. Bobby Doyon have both resigned as members of the Board of Directors.
Mr. Borch is reducing his general business and board commitments currently. Mr. Doyon wishes to focus his time and efforts on his professional duties and commitments. Both directors were planned, and had accepted, to be vacating their board seats at the company upon the planned closing of the proposed business combination with Global Cannabinoids.
EXM and the Board are currently evaluating candidates with respect to appointing two new independent directors to fill the two current vacancies.
The Board of Directors would like to thank both Mr. Borch and Mr. Doyon for their meaningful contribution over the past few years and wish them well in all their future endeavors.
ON BEHALF OF THE BOARD OF DIRECTORS OF EXMCEUTICALS INC.
Jonathan Summers, Chairman and Chief Executive Officer
For further information, contact:
Investor Relations
Email: investors@exmceuticals.com
FOR MORE UPDATES ON THE COMPANY
Follow us on Twitter: https://twitter.com/EXMceuticals
Follow us on LinkedIn: https://www.linkedin.com/company/exmceuticalsinc/
GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…
Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…
Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at…
LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…
Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…